In summary, this systematic meta-analysis suggests a crucial role for the rs743572 polymorphism in cancer pathogenesis, with particular prominence observed in bladder cancer, breast cancer, non-Hodgkin lymphoma, and hepatocellular cancer—a noteworthy observation supported by FPRP evaluation. The gene discussed is PTGFRN; the disease is non-Hodgkin lymphoma.